(Q41260361)

28 September 2017

1 reference

title

Gemcitabine and radiosensitization in human tumor cells (English)

1 reference

28 September 2017

D S Shewach

1

1 reference

28 September 2017

T S Lawrence

series ordinal

2

1 reference

28 September 2017

publication date

1 January 1996

1 reference

Investigational New Drugs

28 September 2017

published in

1 reference

28 September 2017

volume

14

1 reference

28 September 2017

issue

3

1 reference

28 September 2017

page(s)

257-263

1 reference

Fluorodeoxyuridine-induced radiosensitization and inhibition of DNA double strand break repair in human colon cancer cells

28 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00194528

Action of 2',2'-difluorodeoxycytidine on DNA synthesis

21 January 2018

1 reference

12 December 2020

Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).

1 reference

12 December 2020

Cellular elimination of 2',2'-difluorodeoxycytidine 5'-triphosphate: a mechanism of self-potentiation

1 reference

12 December 2020

Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I study

1 reference

12 December 2020

Pharmacologically directed design of the dose rate and schedule of 2',2'-difluorodeoxycytidine (Gemcitabine) administration in leukemia

1 reference

12 December 2020

Nucleotide specificity of human deoxycytidine kinase

1 reference

12 December 2020

Effect of a template-located 2',2'-difluorodeoxycytidine on the kinetics and fidelity of base insertion by Klenow (3'-->5'exonuclease-) fragment.

1 reference

12 December 2020

Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study

1 reference

12 December 2020

Preclinical in vivo activity of 2',2'-difluorodeoxycytidine (Gemcitabine) against human head and neck cancer

1 reference

12 December 2020

The combined effect of hydroxyurea and x-rays on Chinese hamster cells in vitro

1 reference

12 December 2020

Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine

1 reference

12 December 2020

2'-Deoxy-2'-methylenecytidine and 2'-deoxy-2',2'-difluorocytidine 5'-diphosphates: potent mechanism-based inhibitors of ribonucleotide reductase

1 reference

12 December 2020

Saturation of 2',2'-difluorodeoxycytidine 5'-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine

1 reference

12 December 2020

Advanced breast cancer: a phase II trial with gemcitabine

1 reference

12 December 2020

Changes in Radiosensitivity and Dispersion of Chromatin during the Cell Cycle of Synchronous Chinese Hamster Cells

1 reference

12 December 2020

Decrease in TTP pools mediated by 5-bromo-2'-deoxyuridine exposure in a human glioblastoma cell line

1 reference

12 December 2020

Ribonucleotide reductases

1 reference

12 December 2020

Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) in previously treated ovarian cancer patients

1 reference

12 December 2020

The effect of single versus double-strand substitution on halogenated pyrimidine-induced radiosensitization and DNA strand breakage in human tumor cells

1 reference

12 December 2020

Modulation of deoxycytidylate deaminase in intact human leukemia cells. Action of 2',2'-difluorodeoxycytidine

1 reference

12 December 2020

Schedule dependence of sensitivity to 2',2'-difluorodeoxycytidine (Gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumours

1 reference

12 December 2020

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine

1 reference

12 December 2020

Metabolism of 2',2'-difluoro-2'-deoxycytidine and radiation sensitization of human colon carcinoma cells

1 reference

12 December 2020

The effects of incorporation of 5-halogenated deoxyuridines into the DNA of eukaryotic cells

1 reference

12 December 2020

Variations in several responses of HeLa cells to x-irradiation during the division cycle

1 reference

12 December 2020

Gemcitabine: current status of phase I and II trials

1 reference

12 December 2020

Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidine

1 reference

12 December 2020

Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine

1 reference

12 December 2020

Enhancement of X ray induced DNA damage by pre-treatment with halogenated pyrimidine analogs

1 reference

12 December 2020

Clinical and preclinical activity of 2',2'-difluorodeoxycytidine (gemcitabine).

1 reference

12 December 2020

Gemcitabine in leukemia: a phase I clinical, plasma, and cellular pharmacology study

1 reference

12 December 2020

Variation through the cell cycle in the dose-response of DNA neutral filter elution in X-irradiated synchronous CHO-cells

1 reference

12 December 2020

2',2'-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell lines

1 reference

12 December 2020

A pilot study of protracted venous infusion of 5-fluorouracil and concomitant radiation therapy

1 reference

12 December 2020

Differences in inhibition by beta-arabinofuranosyladenine (araA) of radiation induced DNA damage repair in exponentially growing and plateau-phase CHO-cells

1 reference

12 December 2020

Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine

1 reference

12 December 2020

X-ray sensitization by halopyrimidines

1 reference

12 December 2020

The potentiation of radiation response on murine tumor by fludarabine phosphate

1 reference

12 December 2020

Development and molecular characterization of a 2',2'-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780.

1 reference

12 December 2020

Effect of 2',2'-difluorodeoxycytidine on the viability and radiosensitivity of EMT6 cells in vitro

1 reference

12 December 2020

Molecular effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on DNA replication in intact HL-60 cells

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00194528

1 reference

Dimensions Publication ID

28 September 2017

1015899588

0 references

1 reference